New hope for septic shock: could a different drug save more lives?
NCT ID NCT06746753
First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 28 times
Summary
This study looks at two medicines that raise blood pressure in people with septic shock, a life-threatening condition. It compares a newer drug, Angiotensin II, to the standard treatment, norepinephrine. The goal is to see which works better and find ways to predict how severe the shock is. About 78 adults with septic shock will take part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEPTIC SHOCK are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Atrium Health Wake Forest Baptist
Winston-Salem, North Carolina, 27157, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Massachusetts General Hospital-Harvard
Boston, Massachusetts, 02114, United States
Contact Email: •••••@•••••
Contact
Contact
Contact
Contact Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.